BioSpace News Archive

Avalo Therapeutics, Inc. announced that Garry A. Neil, M.D., President and Chief Executive Officer, will present virtually at Oppenheimer’s 33rd Annual Healthcare Conference on Monday, March 13, 2023 at 1:20 p.m. ET.

AB2 Bio Ltd. announced the completion of enrolment of its ongoing pivotal Phase 3 study of Tadekinig alfa.

MRM Health provided a business update on its different ongoing therapeutic programs and an outlook for 2023.

While Electronic Health Records improve access to patient information, charting increases the clerical burden on physicians as medical documentation has been identified as a contributing factor to burnout.

Opthea Limited, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced that it has received an A$8.7 million research and development tax credit from the Australian Taxation Office.

Theratechnologies Inc. announced receipt of a notification letter from The Nasdaq Stock Market LLC dated March 3, 2023, advising that the Company was not in compliance with Listing Rule 5550 as the bid price of the Company’s listed securities had closed at less than US$1.00 per share over the last 30 consecutive business days from January 19, 2023 to March 2, 2023.

Axonics, Inc. is participating as a platinum sponsor of the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2023 Winter Meeting, which is being held in Nashville from March 7-11.

Thomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023, at 12:00 p.m. (ET).

Neuromod Devices Ltd. announced today that the US Food and Drug Administration (FDA) has granted De Novo approval to Lenire, the first bimodal neuromodulation device of its kind to be approved by the FDA for the treatment of tinnitus.

NovaBay Pharmaceuticals Launches Avenova ® Eye Health Support, a New Antioxidant-Rich Oral Supplement to Comfort Dry Eyes and Promote Overall Eye Health.